Headache on Wegovy, Saxenda, Foundayo and other GLP-1 medicines
The short answer
Wegovy headache was reported by 14% of adults on 2.4 mg against 10% on placebo. Two other GLP-1 labels also list headache in their tables: Saxenda (13.6% against 12.6%) and Foundayo (8% to 9% against 7%). It isn't listed in the tables of the Zepbound, Mounjaro, Ozempic, Rybelsus or Trulicity labels. Tell your prescriber about headaches that are new, frequent or severe.
Key takeaways
- Three labels list headache: Wegovy, Saxenda and Foundayo. In those three, placebo groups reported it almost as often.
- A missing table row doesn't prove a medicine can't be involved in a headache.
- Tell your prescriber about headaches that are new, frequent or severe since you started or stepped up a dose.
- A sudden, severe headache, or one with confusion, weakness or vision changes, is an emergency: call 911.
- Ask your pharmacist which pain reliever is appropriate with your other medicines.
How often it was reported in the label's trials
| Reaction | Placebon=1261 | Wegovy injection 2.4 mg once weeklyn=2116 |
|---|---|---|
| Headache | 10% | 14% |
| Reaction | Placebon=303 | Wegovy injection 2.4 mg once weeklyn=304 | Wegovy injection 7.2 mg once weeklyn=1311 |
|---|---|---|---|
| Headache | 7% | 8% | 9% |
| Reaction | Placebon=67 | Wegovy injection 2.4 mg once weeklyn=133 |
|---|---|---|
| Headache | 16% | 17% |
| Reaction | Placebon=1576 | 5.5 mgn=1051 | 9 mgn=1055 | 17.2 mgn=1049 |
|---|---|---|---|---|
| Headache | 7% | 8% | 9% | 9% |
| Reaction | Placebon=1941 | Saxendan=3384 |
|---|---|---|
| Headache | 12.6% | 13.6% |
Each medicine's figures come from its own trials, which differ in dose, length and who took part. They are not a head-to-head comparison.
If you’re getting headaches on a GLP-1 medicine, tell your prescriber if they’re new, frequent or severe since you started the medicine or stepped up a dose. A sudden, severe headache, or one with confusion, weakness or changes in vision, is an emergency whatever medicine you take: call 911.
Headache is the reaction where the labels disagree most about whether there’s anything to report. Three list it. Five don’t. And in the three that do, the placebo groups reported headache almost as often as the treated groups. A placebo group gets an inactive treatment instead of the medicine.
The three labels that list headache
Wegovy. In three trials of the 2.4 mg injection in adults with obesity or overweight, treated for up to 68 weeks, headache was reported by 14% on Wegovy and 10% on placebo. In the two trials of the 7.2 mg dose in adults with obesity: 9% on 7.2 mg, 8% on 2.4 mg and 7% on placebo. In the trial of adolescents aged 12 and older with obesity: 17% on Wegovy 2.4 mg and 16% on placebo.
Saxenda. In five trials in adults with overweight or obesity: 13.6% on Saxenda and 12.6% on placebo. Headache isn’t listed in the Saxenda label’s adolescent table.
Foundayo. In two pooled trials in adults with obesity or overweight, treated for up to 72 weeks: 8% at 5.5 mg, 9% at 9 mg and 9% at 17.2 mg, with 7% on placebo.
How small the gap is
Put the treated and placebo figures side by side:
- Wegovy 2.4 mg, adults: four percentage points.
- Wegovy 7.2 mg trials: two points for 7.2 mg, one point for 2.4 mg.
- Wegovy 2.4 mg, adolescents: one point.
- Saxenda, adults: one point.
- Foundayo: one to two points.
Headache is among the most common complaints in any trial, and these tables show it. Between 7% and 16% of people taking a placebo reported one. The Wegovy and Saxenda tables include any reaction above their cutoff that was reported more often on the medicine than on placebo, by any margin. So a place in the table doesn’t mean the difference was large.
All three labels come from weight management trials. They were run separately, so don’t compare the three sets of figures with each other.
The five labels that do not list it
Headache isn’t listed in the label’s table for:
- Zepbound, whose table covers reactions reported by at least 2% of patients and more often than on placebo in its two weight reduction trials;
- Mounjaro, Ozempic, Rybelsus and Trulicity, whose tables cover reactions reported by at least 5% of patients in type 2 diabetes trials.
Be careful about what that shows. Headaches may well have been reported in those trials. The tables only tell you headache didn’t meet the label’s reporting rule. In a table that requires a reaction to be more frequent than on placebo, a headache rate equal to or below the placebo rate wouldn’t appear, however common headaches were.
Dizziness, a neighboring row
If you’re looking up headache, you may mean lightheadedness as well. The labels report dizziness more widely:
- Wegovy 2.4 mg, adults: 8%, with 4% on placebo. Adolescents: 8%, with 3% on placebo.
- Saxenda, adults: 6.9%, with 5% on placebo. Adolescents: 10.4%, with 3.2% on placebo.
- Zepbound: 4% at 5 mg, 5% at 10 mg and 4% at 15 mg, with 2% on placebo.
- Foundayo, in text: 4% of treated patients and 3% on placebo.
The Saxenda label says dizziness, along with fatigue and related events, was mainly reported within the first 12 weeks of treatment. It adds that these were often reported along with gastrointestinal (stomach and bowel) events such as nausea, vomiting and diarrhea. It makes no such statement about headache, and no label in our records says when headaches occurred or how long they lasted.
Related warnings
No warning in our records lists headache as a symptom. Three warnings are relevant to the things that can come with a headache:
- Dehydration. Every label warns of acute kidney injury due to volume depletion (losing too much fluid), mostly in patients whose nausea, vomiting or diarrhea led to dehydration.
- Low blood pressure. The Wegovy label reports hypotension-related reactions (linked to low blood pressure) in 1.3% of treated adults against 0.4% on placebo, and fainting in 0.8% against 0.2%. The Saxenda label reports 1.1% against 0.5%.
- Hypoglycemia. Each label warns that low blood sugar is more likely when the medicine is combined with insulin or a sulfonylurea, a type of diabetes pill. Ask your prescriber or pharmacist what to watch for if you take either.
When to contact your prescriber
Tell your prescriber about headaches that are new, frequent or severe since you started the medicine or stepped up a dose. Mention anything that comes with them, such as vomiting, diarrhea, dizziness or fainting. A sudden, severe headache, or one with confusion, weakness or changes in vision, is an emergency whatever medicine you take: call 911.
Ask your pharmacist which pain reliever is appropriate with your other medicines. We don’t suggest changing a dose.
Related: fatigue, the side effects overview, Wegovy and Saxenda.
Frequently asked questions
Does Wegovy cause headaches?
Yes, headache is in the Wegovy label's table. Across three weight reduction trials in adults, 14% of patients on the 2.4 mg injection reported it, against 10% on placebo. In the later trials of the 7.2 mg dose, the figures were 9% on 7.2 mg, 8% on 2.4 mg and 7% on placebo.
Does Ozempic cause headaches?
Headache isn't listed in the Ozempic label's table, which covers reactions reported by at least 5% of patients in its type 2 diabetes trials. That tells you it didn't meet the table's cutoff. It doesn't prove that Ozempic can't be involved in a headache.
Does Zepbound or Mounjaro cause headaches?
Headache isn't listed in either label's table. Zepbound's table covers reactions reported by at least 2% of patients and more often than on placebo, and Mounjaro's covers those reported by at least 5%. Zepbound's table does list dizziness, at 4% to 5% against 2% on placebo.
When should I worry about a headache on a GLP-1?
No warning in the label records we hold names headache. Contact your prescriber if headaches are new, frequent or severe after starting or increasing a dose, or if they come with vomiting, diarrhea, dizziness or fainting. A sudden severe headache, or one with confusion, weakness or vision changes, needs emergency care whatever medicine you take.
Sources (8)
- 1.
- 2.
- 3.
- 4.
- 5.
- 6.
- 7.
- 8.
Related pages
- GLP-1 side effects: what the FDA labels report
- Does Ozempic make you tired? Fatigue in the GLP-1 labels
- Ozempic nausea, Zepbound nausea and the other GLP-1 labels
- What is Wegovy? Uses, doses, pill and pen, and cost
- Saxenda (liraglutide): uses, doses, cost and how to take it
- Injection site reactions on Zepbound, Saxenda, Wegovy and other GLP-1 injections
